<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01865513</url>
  </required_header>
  <id_info>
    <org_study_id>POPULAR</org_study_id>
    <nct_id>NCT01865513</nct_id>
  </id_info>
  <brief_title>POPULAR: POst-operative PULmonary Complications After Use of Muscle Relaxants in Europe</brief_title>
  <acronym>POPULAR</acronym>
  <official_title>POPULAR: POst-operative PULmonary Complications After Use of Muscle Relaxants in Europe - A European Prospective Multicenter Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European Society of Anaesthesiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>European Society of Anaesthesiology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      International multicenter observational study of a random-sample cohort of patients&#xD;
      undergoing any in-hospital surgical procedure under general or regional anaesthesia during a&#xD;
      continued 14-day period of recruitment.&#xD;
&#xD;
      Primary hypothesis of this study is that the use of muscle relaxants, their reversal agents,&#xD;
      or neuromuscular monitoring increases the incidence of postoperative pulmonary complications.&#xD;
      The secondary hypothesis is that the use of muscle relaxants increases in-hospital mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overall postoperative mortality for patients undergoing non-cardiac surgery in Europe is 4%&#xD;
      (EUSOS study). Postoperative pulmonary complications are a major factor, which increase&#xD;
      patient morbidity and mortality (PERISCOPE study). This study is designed to evaluate the&#xD;
      effects of management of neuromuscular blockade on postoperative pulmonary complications in a&#xD;
      general unrestricted anaesthetized population across Europe. The investigation will be a&#xD;
      continuation of the European EUSOS and PERISCOPE studies. Based on a well-recognised body of&#xD;
      surrogate data, it is hypothesized that incorrect approaches to the use, monitoring, and&#xD;
      reversal of muscle relaxants will increase the incidence of in-hospital postoperative&#xD;
      pulmonary complications and prolong hospital stay.&#xD;
&#xD;
      The investigators will not modify a participating centre's customary management of patients.&#xD;
      Patients with postoperative pulmonary complications will be identified by postoperative&#xD;
      assessment and consulting medical records for events that fulfil the definition of&#xD;
      postoperative pulmonary complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary study outcome parameter is the rate of post-operative pulmonary Complications (POPC).</measure>
    <time_frame>up to 28 days after surgery</time_frame>
    <description>Post-operative pulmonary Complications (POPC) is a composite of in-hospital fatal or non-fatal postoperative pulmonary events. A patient is assumed to have POPC if at least one of the following complications is documented:&#xD;
POPC is defined as a composite of in-hospital fatal or non-fatal postoperative pulmonary or respiratory events:&#xD;
Respiratory failure Suspected pulmonary infection, i.e. Suspected pulmonary infiltrates Atelectasis Aspiration pneumonitis Bronchospasm Pulmonary Oedema</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>in-hospital mortality</measure>
    <time_frame>up to 28 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of in-hospital stay</measure>
    <time_frame>up to 28 days after surgery</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">22000</enrollment>
  <condition>Surgical Procedures, Operative</condition>
  <condition>Anaesthesia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Patients undergoing any in-hospital surgical procedure under general or regional&#xD;
        anaesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult Patients undergoing any in-hospital surgical procedure under general or regional&#xD;
             anaesthesia during the defined continued 14-day period of recruitment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients less than 18 years of age&#xD;
&#xD;
          2. Patients scheduled for local or regional anaesthesia only&#xD;
&#xD;
          3. Patient's anaesthetic procedure scheduled outside an operating room&#xD;
&#xD;
          4. Ambulatory patients = Patient planned to be discharged within 12 hours post&#xD;
             anaesthesia&#xD;
&#xD;
          5. Patient with preoperatively intubated trachea&#xD;
&#xD;
          6. Patient from an intensive care unit (ICU)&#xD;
&#xD;
          7. Patient scheduled for additional surgical / anaesthetic procedure in the next 7 days&#xD;
&#xD;
          8. Patients who had a surgical / anaesthetic procedure within the past 7 days&#xD;
&#xD;
          9. Patient born outside the predetermined 'month(s)' allocated for the specific study&#xD;
             centre.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred Blobner, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Klinikum rechts der Isar Technische Universität München</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum rechts der Isar, Technische Universität München</name>
      <address>
        <city>München</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Institutet and Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <study_first_submitted>May 28, 2013</study_first_submitted>
  <study_first_submitted_qc>May 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2013</study_first_posted>
  <last_update_submitted>October 13, 2015</last_update_submitted>
  <last_update_submitted_qc>October 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anaesthesia</keyword>
  <keyword>Anaesthesiology</keyword>
  <keyword>muscle Relaxants</keyword>
  <keyword>POPULAR</keyword>
  <keyword>postoperative pulmonary complications</keyword>
  <keyword>Respiratory failure</keyword>
  <keyword>Suspected pulmonary infection</keyword>
  <keyword>Pulmonary infiltrates</keyword>
  <keyword>Pleural effusion</keyword>
  <keyword>Atelectasis</keyword>
  <keyword>Pneumothorax</keyword>
  <keyword>Bronchospasm</keyword>
  <keyword>Aspiration pneumonitis</keyword>
  <keyword>Cardiopulmonary oedema</keyword>
  <keyword>European Society of Anaesthesiology</keyword>
  <keyword>neuromuscular blockade</keyword>
  <keyword>europe</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Hypotonia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

